Aspen Aerogels (ASPN) Tops Q2 EPS by 15c; Offers FY23 Revenue Guidance
Get Alerts ASPN Hot Sheet
Price: $5.05 -6.31%
Revenue Growth %: -2.6%
Financial Fact:
Total operating expenses: 2.6M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -2.6%
Financial Fact:
Total operating expenses: 2.6M
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.22), $0.15 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.81 million.
GUIDANCE:
Aspen Aerogels sees FY2023 revenue of $200-250 million, versus the consensus of $225.7 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share